SARS-CoV-2

Biodefense Headlines – 6 December 2024

News Scan December 6, 2024

This week’s topics include new rules on testing unpasteurized milk for H5N1, investing in a vaccine stockpile for a bird flu pandemic, the state of the U.S. biomedical research enterprise,…

Many Children Hospitalized with COVID-19 or MIS-C Have Lingering Complications Months Later

Children Infected with a Mild Case of COVID-19 Can Still Develop Long COVID Symptoms

Long COVID: National Academies’ Panel Examines Long-Term Health Effects of COVID-19

Pathogen Crescendo: Brass, Woodwinds Section Emit Respiratory Particles

Adverse Events After Simultaneous COVID-19 mRNA Booster, Flu Vaccination

How a COVID-19 Infection Spurs Antibodies Against Common Colds

Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

We’ll See More ‘Hybrids’ Like Omicron XE as COVID Continues to Evolve

Northwestern University Researchers Develop Nanoparticle Vaccine Platform

Will the BA.2 Subvariant Cause Another Wave of Infections in the US?

As New Zealand Relaxes Restrictions, Steps Can Still Be Taken to Limit COVID Infections

Some PASC Patients May Experience Long-Lasting Airway Disease — Even if They Only Had Mild COVID-19

Neurological Symptoms are Present in Roughly Two-Thirds of Hospitalized COVID-19 Patients

U.S. Opens Funding for New Public Health Pathogens Genomics Centers of Excellence

Even Mild or Moderate COVID-19 Illness Affects Cardiovascular System in Young Adults

Rapid COVID-19 PCR Test Developed at Northwestern Receives FDA Emergency Use Authorization

New NIH Study Will Follow Patients That Had Allergic Reaction to mRNA COVID-19 Vaccines

Antivirals, Some Antibodies, Work Well Against BA.2 Omicron Variant of COVID-19 Virus

Even Mild Cases of COVID-19 Can Leave a Mark on the Brain — Such as Reductions in Gray Matter

Particles Carrying Viruses Likely Travel Farther Than Previously Thought

Biodefense Headlines – 6 December 2024